schliessen

Filtern

 

Bibliotheken

Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells

P-glycoprotein (P-gp or MDR1) is an ATP-binding cassette (ABC) transporter. It is involved in the efflux of several anticancer drugs, which leads to chemotherapy failure and multidrug resistance (MDR) in cancer cells. Representative secondary metabolites (SM) including phenolics (EGCG and thymol), t... Full description

Journal Title: Phytomedicine (Stuttgart) 2013-12-15, Vol.21 (1), p.47-61
Main Author: Eid, Safaa Yehia
Other Authors: El-Readi, Mahmoud Zaki , Eldin, Essam Eldin Mohamed Nour , Fatani, Sameer Hassan , Wink, Michael
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: Alma/SFX Local Collection
Publisher: Germany: Elsevier GmbH
ID: ISSN: 0944-7113
Link: https://www.ncbi.nlm.nih.gov/pubmed/23999162
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_gale_infotracacademiconefile_A355468302
title: Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells
format: Article
creator:
  • Eid, Safaa Yehia
  • El-Readi, Mahmoud Zaki
  • Eldin, Essam Eldin Mohamed Nour
  • Fatani, Sameer Hassan
  • Wink, Michael
subjects:
  • Alkaloids
  • Alkaloids - pharmacology
  • Alkaloids - therapeutic use
  • Antineoplastic Agents, Phytogenic - pharmacology
  • Antineoplastic Agents, Phytogenic - therapeutic use
  • ATP-Binding Cassette, Sub-Family B, Member 1 - genetics
  • ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism
  • Benzophenanthridines - pharmacology
  • Benzophenanthridines - therapeutic use
  • beta Carotene - pharmacology
  • beta Carotene - therapeutic use
  • Caco-2 Cells
  • Cancer cells
  • Colon cancer
  • Colon cells
  • Colonic Neoplasms - drug therapy
  • Colonic Neoplasms - genetics
  • Colonic Neoplasms - metabolism
  • Digitonin
  • Digitonin - pharmacology
  • Digitonin - therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Drug Resistance, Multiple - drug effects
  • Drug Resistance, Neoplasm - drug effects
  • Drug Synergism
  • Drug therapy
  • Drug therapy, Combination
  • Fluoresceins - metabolism
  • Health aspects
  • Humans
  • Isoquinolines - pharmacology
  • Isoquinolines - therapeutic use
  • Leukaemia
  • Leukemia - drug therapy
  • Leukemia - genetics
  • Leukemia - metabolism
  • Multidrug resistance
  • Phenols - pharmacology
  • Phenols - therapeutic use
  • Physiological aspects
  • Phytochemicals - pharmacology
  • Phytochemicals - therapeutic use
  • Phytotherapy
  • Plant Extracts - pharmacology
  • Plant Extracts - therapeutic use
  • Rhodamine 123 - metabolism
  • RNA, Messenger - metabolism
  • Sanguinarine
  • Terpenes - pharmacology
  • Terpenes - therapeutic use
  • β-Carotene
ispartof: Phytomedicine (Stuttgart), 2013-12-15, Vol.21 (1), p.47-61
description: P-glycoprotein (P-gp or MDR1) is an ATP-binding cassette (ABC) transporter. It is involved in the efflux of several anticancer drugs, which leads to chemotherapy failure and multidrug resistance (MDR) in cancer cells. Representative secondary metabolites (SM) including phenolics (EGCG and thymol), terpenoids (menthol, aromadendrene, β-sitosterol-O-glucoside, and β-carotene), and alkaloids (glaucine, harmine, and sanguinarine) were evaluated as potential P-gp inhibitors (transporter activity and expression level) in P-gp expressing Caco-2 and CEM/ADR5000 cancer cell lines. Selected SM increased the accumulation of the rhodamine 123 (Rho123) and calcein-AM (CAM) in a dose dependent manner in Caco-2 cells, indicating that they act as competitive inhibitors of P-gp. Non-toxic concentrations of β-carotene (40μM) and sanguinarine (1μM) significantly inhibited Rho123 and CAM efflux in CEM/ADR5000 cells by 222.42% and 259.25% and by 244.02% and 290.16%, respectively relative to verapamil (100%). Combination of the saponin digitonin (5μM), which also inhibits P-gp, with SM significantly enhanced the inhibition of P-gp activity. The results were correlated with the data obtained from a quantitative analysis of MDR1 expression. Both compounds significantly decreased mRNA levels of the MDR1 gene to 48% (p
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0944-7113
fulltext: fulltext
issn:
  • 0944-7113
  • 1618-095X
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.485341
LOCALfalse
PrimoNMBib
record
control
sourceidgale_cross
recordidTN_cdi_gale_infotracacademiconefile_A355468302
sourceformatXML
sourcesystemPC
galeidA355468302
sourcerecordidA355468302
originalsourceidFETCH-LOGICAL-c448t-c47c5190c6c1cbe16320b51ceb8a1bfa44ae2939835cbc9d0392c13615b8c5bb3
addsrcrecordideNqFUl2L1DAULaK4s6v_QCSvwrYmTdtpfBCWxdWBBcUP8C2kt7czmc0kJcmsO3_K32i6ddEVURKS3NxzTi45N8ueMVowypqX22LcHHbYFyVlvKDLgjLxIFuwhrU5FfXXh9mCiqrKl4zxo-w4hC2lrBJL-jg7KrkQgjXlIvu-soPZowUkbiDgdp22KmpnwxT3eq2js9qSbzpuSECDELEn4watMxrCKYnoxxToPp2V7YkyV8pMIXGWxA0SvBk9hpAk5zxEfa3jYZL_kK_NAdzoXcT0RpoG91cKd1rdYsGZxAKVqvME0JjwJHs0KBPw6c_9JPty8ebz-bv88v3b1fnZZQ5V1ca0LqFmgkIDDDpkDS9pVzPArlWsG1RVKSwFFy2voQPRUy5KYLxhdddC3XX8JCtm3bUyKLUdXPQK0uhTceAsDjrdn_G6rpqW0zIRnv-FIH8HvLgHSCIRb-Ja7UOQq08f74tVMxa8C8HjIEevd8ofJKNyMl9u5Wy-nMyXdCmT-b9qGPfdlLsj3bmdAK_-0AUdb91OxWrzP_XXMxnTv19r9DKAnhqn1z51heyd_rfAD0rQ2Dw
sourcetypeAggregation Database
isCDItrue
recordtypearticle
display
typearticle
titleInfluence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells
sourceAlma/SFX Local Collection
creatorEid, Safaa Yehia ; El-Readi, Mahmoud Zaki ; Eldin, Essam Eldin Mohamed Nour ; Fatani, Sameer Hassan ; Wink, Michael
creatorcontribEid, Safaa Yehia ; El-Readi, Mahmoud Zaki ; Eldin, Essam Eldin Mohamed Nour ; Fatani, Sameer Hassan ; Wink, Michael
descriptionP-glycoprotein (P-gp or MDR1) is an ATP-binding cassette (ABC) transporter. It is involved in the efflux of several anticancer drugs, which leads to chemotherapy failure and multidrug resistance (MDR) in cancer cells. Representative secondary metabolites (SM) including phenolics (EGCG and thymol), terpenoids (menthol, aromadendrene, β-sitosterol-O-glucoside, and β-carotene), and alkaloids (glaucine, harmine, and sanguinarine) were evaluated as potential P-gp inhibitors (transporter activity and expression level) in P-gp expressing Caco-2 and CEM/ADR5000 cancer cell lines. Selected SM increased the accumulation of the rhodamine 123 (Rho123) and calcein-AM (CAM) in a dose dependent manner in Caco-2 cells, indicating that they act as competitive inhibitors of P-gp. Non-toxic concentrations of β-carotene (40μM) and sanguinarine (1μM) significantly inhibited Rho123 and CAM efflux in CEM/ADR5000 cells by 222.42% and 259.25% and by 244.02% and 290.16%, respectively relative to verapamil (100%). Combination of the saponin digitonin (5μM), which also inhibits P-gp, with SM significantly enhanced the inhibition of P-gp activity. The results were correlated with the data obtained from a quantitative analysis of MDR1 expression. Both compounds significantly decreased mRNA levels of the MDR1 gene to 48% (p<0.01) and 46% (p<0.01) in Caco-2, and to 61% (p<0.05) and 1% (p<0.001) in CEM/ADR5000 cells, respectively as compared to the untreated control (100%). Combinations of digitonin with SM resulted in a significant down-regulation of MDR1. Our findings provide evidence that the selected SM interfere directly and/or indirectly with P-gp function. Combinations of different P-gp substrates, such as digitonin alone and together with the set of SM, can mediate MDR reversal in cancer cells.
identifier
0ISSN: 0944-7113
1EISSN: 1618-095X
2DOI: 10.1016/j.phymed.2013.07.019
3PMID: 23999162
languageeng
publisherGermany: Elsevier GmbH
subjectAlkaloids ; Alkaloids - pharmacology ; Alkaloids - therapeutic use ; Antineoplastic Agents, Phytogenic - pharmacology ; Antineoplastic Agents, Phytogenic - therapeutic use ; ATP-Binding Cassette, Sub-Family B, Member 1 - genetics ; ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism ; Benzophenanthridines - pharmacology ; Benzophenanthridines - therapeutic use ; beta Carotene - pharmacology ; beta Carotene - therapeutic use ; Caco-2 Cells ; Cancer cells ; Colon cancer ; Colon cells ; Colonic Neoplasms - drug therapy ; Colonic Neoplasms - genetics ; Colonic Neoplasms - metabolism ; Digitonin ; Digitonin - pharmacology ; Digitonin - therapeutic use ; Dose-Response Relationship, Drug ; Drug Combinations ; Drug Resistance, Multiple - drug effects ; Drug Resistance, Neoplasm - drug effects ; Drug Synergism ; Drug therapy ; Drug therapy, Combination ; Fluoresceins - metabolism ; Health aspects ; Humans ; Isoquinolines - pharmacology ; Isoquinolines - therapeutic use ; Leukaemia ; Leukemia - drug therapy ; Leukemia - genetics ; Leukemia - metabolism ; Multidrug resistance ; Phenols - pharmacology ; Phenols - therapeutic use ; Physiological aspects ; Phytochemicals - pharmacology ; Phytochemicals - therapeutic use ; Phytotherapy ; Plant Extracts - pharmacology ; Plant Extracts - therapeutic use ; Rhodamine 123 - metabolism ; RNA, Messenger - metabolism ; Sanguinarine ; Terpenes - pharmacology ; Terpenes - therapeutic use ; β-Carotene
ispartofPhytomedicine (Stuttgart), 2013-12-15, Vol.21 (1), p.47-61
rights
02013 Elsevier GmbH
1Copyright © 2013 Elsevier GmbH. All rights reserved.
2COPYRIGHT 2013 Urban & Fischer Verlag
lds50peer_reviewed
citedbyFETCH-LOGICAL-c448t-c47c5190c6c1cbe16320b51ceb8a1bfa44ae2939835cbc9d0392c13615b8c5bb3
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23999162$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Eid, Safaa Yehia
1El-Readi, Mahmoud Zaki
2Eldin, Essam Eldin Mohamed Nour
3Fatani, Sameer Hassan
4Wink, Michael
title
0Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells
1Phytomedicine (Stuttgart)
addtitlePhytomedicine
descriptionP-glycoprotein (P-gp or MDR1) is an ATP-binding cassette (ABC) transporter. It is involved in the efflux of several anticancer drugs, which leads to chemotherapy failure and multidrug resistance (MDR) in cancer cells. Representative secondary metabolites (SM) including phenolics (EGCG and thymol), terpenoids (menthol, aromadendrene, β-sitosterol-O-glucoside, and β-carotene), and alkaloids (glaucine, harmine, and sanguinarine) were evaluated as potential P-gp inhibitors (transporter activity and expression level) in P-gp expressing Caco-2 and CEM/ADR5000 cancer cell lines. Selected SM increased the accumulation of the rhodamine 123 (Rho123) and calcein-AM (CAM) in a dose dependent manner in Caco-2 cells, indicating that they act as competitive inhibitors of P-gp. Non-toxic concentrations of β-carotene (40μM) and sanguinarine (1μM) significantly inhibited Rho123 and CAM efflux in CEM/ADR5000 cells by 222.42% and 259.25% and by 244.02% and 290.16%, respectively relative to verapamil (100%). Combination of the saponin digitonin (5μM), which also inhibits P-gp, with SM significantly enhanced the inhibition of P-gp activity. The results were correlated with the data obtained from a quantitative analysis of MDR1 expression. Both compounds significantly decreased mRNA levels of the MDR1 gene to 48% (p<0.01) and 46% (p<0.01) in Caco-2, and to 61% (p<0.05) and 1% (p<0.001) in CEM/ADR5000 cells, respectively as compared to the untreated control (100%). Combinations of digitonin with SM resulted in a significant down-regulation of MDR1. Our findings provide evidence that the selected SM interfere directly and/or indirectly with P-gp function. Combinations of different P-gp substrates, such as digitonin alone and together with the set of SM, can mediate MDR reversal in cancer cells.
subject
0Alkaloids
1Alkaloids - pharmacology
2Alkaloids - therapeutic use
3Antineoplastic Agents, Phytogenic - pharmacology
4Antineoplastic Agents, Phytogenic - therapeutic use
5ATP-Binding Cassette, Sub-Family B, Member 1 - genetics
6ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism
7Benzophenanthridines - pharmacology
8Benzophenanthridines - therapeutic use
9beta Carotene - pharmacology
10beta Carotene - therapeutic use
11Caco-2 Cells
12Cancer cells
13Colon cancer
14Colon cells
15Colonic Neoplasms - drug therapy
16Colonic Neoplasms - genetics
17Colonic Neoplasms - metabolism
18Digitonin
19Digitonin - pharmacology
20Digitonin - therapeutic use
21Dose-Response Relationship, Drug
22Drug Combinations
23Drug Resistance, Multiple - drug effects
24Drug Resistance, Neoplasm - drug effects
25Drug Synergism
26Drug therapy
27Drug therapy, Combination
28Fluoresceins - metabolism
29Health aspects
30Humans
31Isoquinolines - pharmacology
32Isoquinolines - therapeutic use
33Leukaemia
34Leukemia - drug therapy
35Leukemia - genetics
36Leukemia - metabolism
37Multidrug resistance
38Phenols - pharmacology
39Phenols - therapeutic use
40Physiological aspects
41Phytochemicals - pharmacology
42Phytochemicals - therapeutic use
43Phytotherapy
44Plant Extracts - pharmacology
45Plant Extracts - therapeutic use
46Rhodamine 123 - metabolism
47RNA, Messenger - metabolism
48Sanguinarine
49Terpenes - pharmacology
50Terpenes - therapeutic use
51β-Carotene
issn
00944-7113
11618-095X
fulltexttrue
rsrctypearticle
creationdate2013
recordtypearticle
recordideNqFUl2L1DAULaK4s6v_QCSvwrYmTdtpfBCWxdWBBcUP8C2kt7czmc0kJcmsO3_K32i6ddEVURKS3NxzTi45N8ueMVowypqX22LcHHbYFyVlvKDLgjLxIFuwhrU5FfXXh9mCiqrKl4zxo-w4hC2lrBJL-jg7KrkQgjXlIvu-soPZowUkbiDgdp22KmpnwxT3eq2js9qSbzpuSECDELEn4watMxrCKYnoxxToPp2V7YkyV8pMIXGWxA0SvBk9hpAk5zxEfa3jYZL_kK_NAdzoXcT0RpoG91cKd1rdYsGZxAKVqvME0JjwJHs0KBPw6c_9JPty8ebz-bv88v3b1fnZZQ5V1ca0LqFmgkIDDDpkDS9pVzPArlWsG1RVKSwFFy2voQPRUy5KYLxhdddC3XX8JCtm3bUyKLUdXPQK0uhTceAsDjrdn_G6rpqW0zIRnv-FIH8HvLgHSCIRb-Ja7UOQq08f74tVMxa8C8HjIEevd8ofJKNyMl9u5Wy-nMyXdCmT-b9qGPfdlLsj3bmdAK_-0AUdb91OxWrzP_XXMxnTv19r9DKAnhqn1z51heyd_rfAD0rQ2Dw
startdate20131215
enddate20131215
creator
0Eid, Safaa Yehia
1El-Readi, Mahmoud Zaki
2Eldin, Essam Eldin Mohamed Nour
3Fatani, Sameer Hassan
4Wink, Michael
general
0Elsevier GmbH
1Urban & Fischer Verlag
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
8IOF
sort
creationdate20131215
titleInfluence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells
authorEid, Safaa Yehia ; El-Readi, Mahmoud Zaki ; Eldin, Essam Eldin Mohamed Nour ; Fatani, Sameer Hassan ; Wink, Michael
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c448t-c47c5190c6c1cbe16320b51ceb8a1bfa44ae2939835cbc9d0392c13615b8c5bb3
rsrctypearticles
prefilterarticles
languageeng
creationdate2013
topic
0Alkaloids
1Alkaloids - pharmacology
2Alkaloids - therapeutic use
3Antineoplastic Agents, Phytogenic - pharmacology
4Antineoplastic Agents, Phytogenic - therapeutic use
5ATP-Binding Cassette, Sub-Family B, Member 1 - genetics
6ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism
7Benzophenanthridines - pharmacology
8Benzophenanthridines - therapeutic use
9beta Carotene - pharmacology
10beta Carotene - therapeutic use
11Caco-2 Cells
12Cancer cells
13Colon cancer
14Colon cells
15Colonic Neoplasms - drug therapy
16Colonic Neoplasms - genetics
17Colonic Neoplasms - metabolism
18Digitonin
19Digitonin - pharmacology
20Digitonin - therapeutic use
21Dose-Response Relationship, Drug
22Drug Combinations
23Drug Resistance, Multiple - drug effects
24Drug Resistance, Neoplasm - drug effects
25Drug Synergism
26Drug therapy
27Drug therapy, Combination
28Fluoresceins - metabolism
29Health aspects
30Humans
31Isoquinolines - pharmacology
32Isoquinolines - therapeutic use
33Leukaemia
34Leukemia - drug therapy
35Leukemia - genetics
36Leukemia - metabolism
37Multidrug resistance
38Phenols - pharmacology
39Phenols - therapeutic use
40Physiological aspects
41Phytochemicals - pharmacology
42Phytochemicals - therapeutic use
43Phytotherapy
44Plant Extracts - pharmacology
45Plant Extracts - therapeutic use
46Rhodamine 123 - metabolism
47RNA, Messenger - metabolism
48Sanguinarine
49Terpenes - pharmacology
50Terpenes - therapeutic use
51β-Carotene
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Eid, Safaa Yehia
1El-Readi, Mahmoud Zaki
2Eldin, Essam Eldin Mohamed Nour
3Fatani, Sameer Hassan
4Wink, Michael
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
7Gale General OneFile
jtitlePhytomedicine (Stuttgart)
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Eid, Safaa Yehia
1El-Readi, Mahmoud Zaki
2Eldin, Essam Eldin Mohamed Nour
3Fatani, Sameer Hassan
4Wink, Michael
formatjournal
genrearticle
ristypeJOUR
atitleInfluence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells
jtitlePhytomedicine (Stuttgart)
addtitlePhytomedicine
date2013-12-15
risdate2013
volume21
issue1
spage47
epage61
pages47-61
issn0944-7113
eissn1618-095X
abstractP-glycoprotein (P-gp or MDR1) is an ATP-binding cassette (ABC) transporter. It is involved in the efflux of several anticancer drugs, which leads to chemotherapy failure and multidrug resistance (MDR) in cancer cells. Representative secondary metabolites (SM) including phenolics (EGCG and thymol), terpenoids (menthol, aromadendrene, β-sitosterol-O-glucoside, and β-carotene), and alkaloids (glaucine, harmine, and sanguinarine) were evaluated as potential P-gp inhibitors (transporter activity and expression level) in P-gp expressing Caco-2 and CEM/ADR5000 cancer cell lines. Selected SM increased the accumulation of the rhodamine 123 (Rho123) and calcein-AM (CAM) in a dose dependent manner in Caco-2 cells, indicating that they act as competitive inhibitors of P-gp. Non-toxic concentrations of β-carotene (40μM) and sanguinarine (1μM) significantly inhibited Rho123 and CAM efflux in CEM/ADR5000 cells by 222.42% and 259.25% and by 244.02% and 290.16%, respectively relative to verapamil (100%). Combination of the saponin digitonin (5μM), which also inhibits P-gp, with SM significantly enhanced the inhibition of P-gp activity. The results were correlated with the data obtained from a quantitative analysis of MDR1 expression. Both compounds significantly decreased mRNA levels of the MDR1 gene to 48% (p<0.01) and 46% (p<0.01) in Caco-2, and to 61% (p<0.05) and 1% (p<0.001) in CEM/ADR5000 cells, respectively as compared to the untreated control (100%). Combinations of digitonin with SM resulted in a significant down-regulation of MDR1. Our findings provide evidence that the selected SM interfere directly and/or indirectly with P-gp function. Combinations of different P-gp substrates, such as digitonin alone and together with the set of SM, can mediate MDR reversal in cancer cells.
copGermany
pubElsevier GmbH
pmid23999162
doi10.1016/j.phymed.2013.07.019
tpages15